340 related articles for article (PubMed ID: 28917451)
1. Postinflammatory hyperpigmentation: A comprehensive overview: Epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique.
Silpa-Archa N; Kohli I; Chaowattanapanit S; Lim HW; Hamzavi I
J Am Acad Dermatol; 2017 Oct; 77(4):591-605. PubMed ID: 28917451
[TBL] [Abstract][Full Text] [Related]
2. Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment.
Kaufman BP; Aman T; Alexis AF
Am J Clin Dermatol; 2018 Aug; 19(4):489-503. PubMed ID: 29222629
[TBL] [Abstract][Full Text] [Related]
3. Postinflammatory hyperpigmentation: A comprehensive overview: Treatment options and prevention.
Chaowattanapanit S; Silpa-Archa N; Kohli I; Lim HW; Hamzavi I
J Am Acad Dermatol; 2017 Oct; 77(4):607-621. PubMed ID: 28917452
[TBL] [Abstract][Full Text] [Related]
4. Dynamic evaluation of an in vivo postinflammatory hyperpigmentation model using reflectance confocal microscopy and spectrophotometry.
Zhao J; Liu Z; Zhang C; Wu J; Huang N; Du Y; Xiang L
J Cosmet Dermatol; 2021 Sep; 20(9):2950-2962. PubMed ID: 33394548
[TBL] [Abstract][Full Text] [Related]
5. Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal.
Park JY; Park JH; Kim SJ; Kwon JE; Kang HY; Lee ES; Kim YC
J Cutan Pathol; 2017 Feb; 44(2):118-124. PubMed ID: 27766668
[TBL] [Abstract][Full Text] [Related]
6. Postinflammatory hyperpigmentation secondary to external insult: an overview of the quantitative analysis of pigmentation.
Lamel SA; Rahvar M; Maibach HI
Cutan Ocul Toxicol; 2013 Mar; 32(1):67-71. PubMed ID: 22667459
[TBL] [Abstract][Full Text] [Related]
7. Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris.
Savory SA; Agim NG; Mao R; Peter S; Wang C; Maldonado G; Bearden Dietert J; Lieu TJ; Wang C; Pretzlaff K; Das S; Vandergriff T; Lopez IE; Litzner BR; Hynan LS; Arellano-Mendoza MI; Bergstresser PR; Pandya AG
J Am Acad Dermatol; 2014 Jan; 70(1):108-14. PubMed ID: 24176524
[TBL] [Abstract][Full Text] [Related]
8. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
Callender VD; St Surin-Lord S; Davis EC; Maclin M
Am J Clin Dermatol; 2011 Apr; 12(2):87-99. PubMed ID: 21348540
[TBL] [Abstract][Full Text] [Related]
9. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
Kroon MW; Wind BS; Meesters AA; Wolkerstorfer A; van der Veen JP; Bos JD; Van der Wal AC; Beek JF
J Dermatolog Treat; 2012 Oct; 23(5):339-44. PubMed ID: 21756152
[TBL] [Abstract][Full Text] [Related]
10. Managing postinflammatory hyperpigmentation in pediatric patients with skin of color.
Heath CR
Cutis; 2019 Feb; 103(2):71-73. PubMed ID: 30893390
[TBL] [Abstract][Full Text] [Related]
11. An in vivo model of postinflammatory hyperpigmentation and erythema: clinical, colorimetric and molecular characteristics.
Vellaichamy G; Kohli I; Zubair R; Yin C; Braunberger T; Nahhas AF; Nicholson C; Mohammad TF; Isedeh P; Lyons AB; Nartker N; Al-Jamal M; Matsui M; Karaman-Jurukovska N; Zhou L; Lim HW; Mi QS; Hamzavi IH
Br J Dermatol; 2022 Mar; 186(3):508-519. PubMed ID: 34625951
[TBL] [Abstract][Full Text] [Related]
12. A focused review on acne-induced and aesthetic procedure-related postinflammatory hyperpigmentation in Asians.
Eimpunth S; Wanitphadeedecha R; Manuskiatti W
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():7-18. PubMed ID: 23205540
[TBL] [Abstract][Full Text] [Related]
13. The effect of menstrual cycle on laser induced hyperpigmentation.
Al Mohizea S
J Drugs Dermatol; 2013 Dec; 12(12):1335-6. PubMed ID: 24301233
[TBL] [Abstract][Full Text] [Related]
14. Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation.
Lyons AB; Kohli I; Nahhas AF; Braunberger TL; Mohammad TF; Nicholson CL; Nartker NT; Modi K; Matsui MS; Lim HW; Hamzavi IH
Arch Dermatol Res; 2020 Dec; 312(10):725-730. PubMed ID: 32253506
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Insights in Melasma and Hyperpigmentation Management.
Huerth KA; Hassan S; Callender VD
J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
[TBL] [Abstract][Full Text] [Related]
16. [Post-inflammatory hyperpigmentation].
Passeron T
Ann Dermatol Venereol; 2016 Dec; 143 Suppl 2():S15-S19. PubMed ID: 29452653
[TBL] [Abstract][Full Text] [Related]
17. Low risk of postinflammatory hyperpigmentation in skin types 4 and 5 after treatment with fractional CO2 laser device.
Tan KL; Kurniawati C; Gold MH
J Drugs Dermatol; 2008 Aug; 7(8):774-7. PubMed ID: 18720695
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a wound-dressing biomaterial on prevention of postinflammatory hyperpigmentation after suction blister epidermal grafting in stable vitiligo patients: a controlled assessor-blinded clinical study with in vitro bioactivity investigation.
Liu Z; Jiang M; Zhao J; Wang Q; Zhang C; Gao M; Gu M; Xiang L
Arch Dermatol Res; 2020 Nov; 312(9):635-645. PubMed ID: 32107629
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo.
Cardinali G; Kovacs D; Picardo M
Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S148-52. PubMed ID: 23522630
[TBL] [Abstract][Full Text] [Related]
20. Normal and abnormal skin color.
Ortonne JP
Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S125-9. PubMed ID: 23522626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
